Business Context and Reporting Period
Company: PMGC Holdings Inc. (Nasdaq: ELAB)
Filing Type: Form 8-K (Current Report)
Date of Report: January 16, 2025
Event: Completion of the disposition of substantially all assets and assignment of certain liabilities related to the skincare and haircare business of its wholly owned subsidiary, Elevai Skincare Inc. (now renamed PMGC Impasse Corp.), to Cutis Cura Corporation and Carmell Corporation (CTCX).
Key Financial Metrics and Transaction Details
This filing details a specific asset disposition rather than a standard periodic financial report. Key transaction metrics include:
- Total Purchase Price: Approximately $1.4 million.
- Consideration Structure:
- Equity: 1,149,226 shares of CTCX Common Stock issued at closing, plus 117,814 shares withheld for 12 months as indemnification security.
- Cash: $56,525 payable within 60 days contingent on the sale of specific inventory units (7,500 Enfinity units and 20,000 Empower tubes).
- Liabilities: Assumption of certain liabilities by the Buyer.
- Earnout Provisions:
- Annual: 5% of Net Sales generated from existing products for five years post-closing.
- One-Time Milestone: $500,000 payment if the Buyer achieves $500,000 in net revenue from existing hair and scalp products within 24 months.
Financial Statements: The filing references unaudited pro forma condensed consolidated statements of income and financial condition filed as Exhibit 99.2, but does not contain the specific numerical values for revenue, profit, cash flow, or debt within the text of this summary.
Material Changes Versus Prior Period
The primary material change is the divestiture of the Elevai Skincare Inc. business unit. Following the closing:
- PMGC Holdings Inc. no longer holds the assets or liabilities associated with the Elevai skincare and haircare business.
- The subsidiary Elevai Skincare Inc. has agreed to change its name to PMGC Impasse Corp.
- The company's future revenue stream from this segment is now limited to potential earnout payments rather than direct product sales.
Guidance, Outlook, and Risks
Management Commentary: The transaction was executed pursuant to an Asset Purchase Agreement dated December 31, 2024, previously disclosed on January 7, 2025. A press release announcing the closing was issued on January 16, 2025.
Risks and Contingencies:
- Contingent Cash Payment: The $56,525 cash component is contingent upon the Buyer selling specific inventory units within 60 days.
- Earnout Uncertainty: Future payments depend on the Buyer's ability to generate specific Net Sales and revenue milestones, which are outside the Company's direct control post-closing.
- Indemnification: A portion of the equity consideration (117,814 shares) is withheld for 12 months to secure indemnification obligations.
Unusual Items: The filing does not disclose unusual items beyond the structural nature of the asset sale and earnout arrangement.
Investor Verification Checklist
- Verify the exact number of CTCX shares issued and the current market value of the equity consideration received.
- Review Exhibit 99.2 for the unaudited pro forma financial impact of this disposition on PMGC's consolidated balance sheet and income statement.
- Confirm the status of the $56,525 cash payment and whether the required inventory units were sold by the Buyer within the 60-day window.
- Monitor future filings for updates on the 5% annual earnout and the $500,000 milestone payment.
- Assess the remaining business operations of PMGC Holdings Inc. post-disposition to understand the company's new strategic focus.